[April 13, 2017 The Board of Directors 48/F., Bank of China Tower, 1 Garden Road, Central, Hong Kong Non-binding Acquisition Proposal dated April 27, 2015 Re: Ladies and Gentlemen: Reference is made to above-described non-binding proposal. In view of the developments regarding Golden Meditech Holding]
[April 13, 2017 The Board of Directors 48/F., Bank of China Tower, 1 Garden Road, Central, Hong Kong Non-binding Acquisition Proposal dated April 27, 2015 Re: Ladies and Gentlemen: Reference is made to above-described non-binding proposal. In view of the developments regarding Golden Meditech Holding]
[China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding Going Private Proposal HONG KONG, China, April 13, 2017 China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoiet]
[China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding Going Private Proposal HONG KONG, China, April 13, 2017 China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoiet]
[O2Micro to Announce First Quarter 2017 Results th GEORGE TOWN, Grand Cayman, April 13, 2017 (GLOBE NEWSWIRE) -- O2Micro® International Limited, (NASDAQ:OIIM), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, will announce its financial r]
[O2Micro to Announce First Quarter 2017 Results th GEORGE TOWN, Grand Cayman, April 13, 2017 (GLOBE NEWSWIRE) -- O2Micro® International Limited, (NASDAQ:OIIM), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, will announce its financial r]
[FORM 10-K (Mark One) ☒ December 31, 2016 For the fiscal year ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) ]
[FORM 10-K (Mark One) ☒ December 31, 2016 For the fiscal year ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) ]
